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Societal impact and valorizations 
In this thesis, state of the art computational approaches of mining non-invasive medical 
imaging data to derive predictive and prognostic inferences in clinical oncology are 
thoroughly described. Although the cohorts employed in this thesis were focused on 
specific oncological diseases – lung cancer and head and neck cancer, the described 
computational approaches harbor broad general applicability. In this section, we discuss 
the foreseeable societal impact of the presented research along with the policies that 
could be followed for the enhancement of personalized medicine.  
We observe an exponential increase in data and information in this recent “big data” 
era. Healthcare is no different to this trend. The healthcare institutions of the devel-
oped countries archive immense amount of patient data and these practices are being 
adopted by the highly populated developing countries as well. This increasing amount 
of patient specific data could transform the routine patient care by tailoring and cus-
tomizing treatments to individuals. More powerful predictive/prognostic tools are be-
coming available, enhancing the routine clinical care. This is aligned with the aimed 
personalized care – bringing the right treatment to the right patient. The use of predic-
tive/prognostic models is increasing, with many online tools already available: 
- http://www.predict.nhs.uk/ is an online tool used to help deciding the ideal course 
of treatment following breast cancer surgery, based on one’s cancer histopathology; 
- http://www.cancer.gov/bcrisktool/ allows estimating woman’s risk of developing 
invasive breast cancer; 
- https://www.mskcc.org/nomograms a long list of nomograms developed for a great 
variety of solid tumors, and based on hundreds or even thousands of patients, can 
be used to predict cancer outcomes or assess disease risk; 
- http://www.predictcancer.org/ a platform making available published models de-
veloped at Maastro for lung, rectum, head and neck, and endometrium cancer 
 
Furthermore, several collaborative consortiums for sharing data have been initiated: 
- http://www.cancerimagingarchive.net/ is an online repository consisting imaging 
and clinical data related to different cancer types. It provides a platform to different 
healthcare institutions of the world to share data and collaborate research. 
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- https://www.cancerdata.org/ is an initiative by Maastro clinic for sharing cancer 
data for research. 
 
We believe that great knowledge gain could be obtained by data sharing. It allows hav-
ing an access of external cohorts for validation, which is essential for the validity of 
research methodologies and proposed hypotheses of data driven research like Radi-
omics. Moreover, data sharing helps in reproducing the successful predictive/prognostic 
models, which latter could also be improved with additional data or by using better 
computational approaches. 
As far as the research presented in this thesis is concerned, majority of the chapters 
employed one or more publicly available data. Furthermore, majority of the applied 
computational approaches and analysis tools are open source.  
The first part of the thesis focused on evaluating different publicly available semi-
automatic segmentation methods keeping in mind their applicability for raidomics. Two 
different semi-automatic segmentation approaches available in a free and publicly 
available 3D-Slicer software tool, were compared to the manual segmentations in terms 
of their efficiency and accuracy. 3D-Slicer is an open source software platform for medi-
cal image informatics, image processing, and three-dimensional visualization. Built over 
two decades through support from the National Institutes of Health and a worldwide 
developer community, Slicer brings free, powerful cross-platform processing tools to 
physicians, researchers, and the general public (https://www.slicer.org). Moreover, all 
the cohorts used in the first part of the thesis are available at TCIA 
(http://www.cancerimagingarchive.net) or at cancerdata.org.  
The second part of the thesis covered the radiomics based predictive/prognostic 
analyses, where different machine learning approaches of feature selection and model-
ling were investigated for the radiomic cohorts of lung and/or head & neck cancer pa-
tients. The work presented in chapter 5, was one of the very first investigations investi-
gating more than 400 quantitative imaging features in over a 1000 patients with lung 
and head and neck cancer, with independent validation datasets. We have shown for 
the first time the true independent validated impact of radiomics in both lung and head 
and neck cancer, showing the translational capability of our findings. Additionally, with 
the publication of the study presented in Chapter 5, we shared imaging datasets to the 
cancer imaging archive (TCIA) of 511 NSCLC patients of which 89 with gene-expression 
data. This again, will facilitate reproducibility of research and allow the investigation of 
other methodologies and hypotheses in the same data. This chapter received attention 
from the media, including a press release from the Maastricht University Medical Cen-
tre1 and an internal press release in the Dana-Farber Cancer Institute in Boston, USA. 
This study was also featured in the outlook issue of the prestigious scientific magazine 
Nature, in a special issue on the outlook of lung cancer2.   
The studies reported in chapters 6-9, were also one of those very first investigations 
investigating the impact of the advanced machine-learning approaches for radiomic 
analyses with large independent validation cohorts and two different cancer types. 
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Predictive and prognostic models with high accuracy, reliability, and efficiency are vital 
factors driving the success of radiomics. Therefore, it is essential to compare different 
machine learning models for radiomics based clinical biomarkers. Moreover, we used 
open source analysis libraries and published parameter settings for the implementation 
of different machine learning methods enabling the unbiased evaluation of these meth-
ods. These articles have received good acceptance from the scientific community result-
ing in a decent number of citations within a short timespan.  
Overall, in order to achieve significantly higher and positive societal impact, collabo-
rative steps in terms of sharing data and knowledge are required. We are actively in-
volved in these initiatives by participating in different data and tools sharing consortium 
and collaborating with different institutions across the glob. Our work has contributed 
towards the release of publicly available radiomics toolboxes3. By involving more institu-
tions in sharing data and knowledge, we can evaluate the validity of radiomics based 
predictive/prognostic models, which could enhance the personalized medicine and 
hence the public health. 
 
(1) http://maastrichtumchoofdsite.createsend1.com/t/ViewEmail/t/CADC497D2FEB9C5D 
(2) http://www.nature.com/nature/journal/v513/n7517_supp/full/513S4a.html 
(3) https://www.radiomics.io/code.html 
  
